Related Experiment Video
Updated: Oct 26, 2025

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients
Bruce A Warden1, Tina Kaufman1, Jessica Minnier1,2
1Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon.
Abstract:
Standard lipid-lowering therapies in solid organ transplantations pose challenges due to interactions with immunosuppressants. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of lipid-lowering therapies with potential promise in this population. We describe PCSK9i as an efficacious and safe option for management of hypercholesterolemia in solid organ transplantations. (Level of Difficulty: Advanced.).
More Related Videos
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction

